Brucellosis is an infectious zoonosis that has huge economic and public health implications globally. The disease is prevalent in humans, livestock and wildlife in Sub-Saharan Africa. A cross-sectional study was conducted between 6 May 2017 and 31 July 2020 during which 1712 sera from 175 cattle herds in five districts from Southern, Western and Eastern Provinces of Zambia were collected and screened against brucellosis. The Rose Bengal Test (RBT) and competitive Enzyme-linked Immuno Assay (c-ELISA) were used in serial testing for the detection of antibodies against Brucella species. A total of 127 animals from 37 herds tested positive, giving overall individual animal and herd-level seroprevalences of 7.53% (95% CI: 6.28–8.78%) and 21.14% (95% CI: 15.0–27.2%), respectively. Namwala district had the highest herd seroprevalence (33.9%, 95% CI: 21.6–46.1%), while Lundazi did not record any seropositivity. Comparably, Southern Province had the highest individual animal (8.97%, 95% CI: 7–11%) and herd-level (28.5%, 95% CI: 20.3–36.7%) seroprevalences, although this was not statistically significant. Within Southern Province, higher seropositivity was observed in Namwala district (OR: 8.55; CI: 2.66–27.44), among female animals (OR: 2.48; CI: 1.38–4.46) and in those aged 11 years and above (OR: 2.67; CI: 1.34–5.34) as well as in gravid cows (OR: 4.34; CI: 2.08–8.92). Seropositivity was also observed among some animals with hygromas (OR: 6.5; CI: 0.45–94.08) and those with a history of abortion (OR: 1.13; CI: 0.18–7.28) although the findings were not statistically significant. Brucella seroprevalence among traditional cattle in Zambia remains high. Control programs against bovine brucellosis must be introduced to reduce its impact on human health and animal production.
Brucellosis is an important zoonotic disease caused by members of the genus Brucella. Camel brucellosis has been reported in almost all camel-rearing countries in Africa and Asia. A cross-sectional study was conducted between February 2020 and February 2021 in Galkayo, Garowe, and Bosaso districts in the Puntland State of Somalia to investigate the seroprevalence and risk factors of brucellosis in camels. A competitive enzyme-linked immunosorbent assay (c-ELISA) was used to detect anti-Brucella antibodies, while a structured questionnaire was used to collect epidemiological data. A total of 441 camel sera were screened against Brucella antibodies. Thirty-one (7%; 95% CI: 4.8–9.8%) samples were positive, and thirteen (54.2%; 95% CI: 32.8–74.4%) out of the twenty-four farms sampled had at least one seropositive animal. Galkayo district had the highest number of Brucella-seropositive camels (10.3%), followed by Bosaso district (8.6%), while Garowe district had the lowest number of seropositive camels (1.4%). The binary logistic regression model revealed that camels in Galkayo district (p = 0.015; OR: 9.428; 95% CI: 1.539–57.755), camels from large herd sizes of >50 animals (p = 0.019; OR: 5.822; 95% CI: 1.336–25.371), and those in contact with small ruminants (p = 0.011; OR: 10.941; 95% CI: 1.728–69.285) were significantly associated with seropositive cases of camel brucellosis in the Puntland State of Somalia. The present study shows that Brucella infections in camels are prevalent in the three districts covered by the study. This poses a public health risk, because milk from these camels is used for human consumption. Studies focusing on the isolation of Brucella strains in camels and investigating brucellosis in ruminants and humans are recommended in the study area. Validation of serological tests—including c-ELISA—for Brucella antibody detection in camels is also needed.
Brucellosis is an infectious zoonosis that has huge economic and public health implications globally. The disease is prevalent in humans, livestock and wildlife in Sub Saharan Africa. A cross-sectional study was conducted between 6th May 2017 and 31st July 2020 during which 1712 sera from 177 cattle herds in Southern, Western and Eastern provinces of Zambia was collected and screened against brucellosis. Rose Bengal Test and c-ELISA were used in serial testing for detection of antibodies against Brucella species. Results: A total of 127 animals and 37 herds tested positive, giving an overall individual and herd seroprevalence of 7.42% (CI: 0.61-0.86) and 20.9% respectively. Namwala district recorded the highest seroprevalence (12.2%) while Lundazi had the lowest (0%). A higher seropositivity was observed among female animals (8.5%), those aged between 11 and 17 years (14.1%) and pregnant cows (13.8%). Conclusions: Brucella seroprevalence among traditional cattle in Zambia remains high. It is vital that control programmes against bovine brucellosis are introduced in order to reduce its zoonotic impact on human health and increase animal production.
Background: Brucellosis is a neglected debilitating zoonosis widely recognized as an occupational health hazard. The seroprevalence of human anti-Brucella antibodies in high-risk populations, as well as their risk factors, have not been well-documented in Zambia. This study aimed at estimating the Brucella seroprevalence in herdsmen and abattoir workers and assess the associated risk factors.Methods: A cross-sectional seroepidemiological study was carried out between May and December 2020 among abattoir workers and herdsmen in Namwala, Monze and Choma districts of Southern Province in Zambia. Seroprevalence was assessed by indirect enzyme-linked immunosorbent assay (i-ELISA) or competitive enzyme-linked immunosorbent assay (c-ELISA) while a questionnaire was administered to obtain epidemiological data.Results: A total of 153 individuals were recruited in the study. The overall Brucella seroprevalence was 20.3% (95% CI: 14.6–27.5). Seropositivity among herdsmen and abattoir workers was 14.4% (95% CI: 9.2–21.8) and 46.4%, (95% CI: 28.8–65.0), respectively. Comparable seropositive results among districts showed Namwala with 26.9%, which was the highest, seconded by Monze 19.0%, and the least was Choma with 11.36%, seropositivity. The multivariate logistic regression model showed that occupation, age category, and district of residence were predictors of being seropositive to Brucella spp. antibodies. The odds of abattoir workers being seropositive to Brucella antibodies were 8.6 (95% CI: 2.6–28.2) higher than that of herdsmen being the reference group. The odds of age category 17–50 years being seropositive to Brucella antibodies were 7.0 (95% CI: 0.7–72.2) higher than being <16 years as the reference group. The odds of one having attained primary level of education being seropositive to Brucella were 1.3 (95% CI: 0.1–14.7) or secondary level of education were 6.2 (95% CI: 0.5–72.6) or tertiary level of education were 5.1 (95% CI: 0.2, 113.3) higher than that of no level of education as the reference group. Furthermore, the odds of a respondent being seropositive to Brucella antibodies were 4.5 (95% CI: 1.3–15.7) for Namwala and 4.9 (95% CI: 1.1–21.7) for Monze higher than that of Choma as the reference group.Conclusion: Anti-Brucella antibodies are prevalent among herdsmen and abattoir workers in the study areas of Zambia (20.26%), a sign of exposure to Brucella pathogens. Type of profession, age and level of education seem to influence the exposure to Brucella pathogens. This zoonosis should be considered as one of the differential diagnosis in humans presenting intermittent fever, malaria-like signs and general pain in humans.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.